2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | 700-800 |
Total Number of Projects: | > 1000 |
Total number of projects: 4
As coordinator: 3
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 3*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 5.999.999 | 1.999.370 | 636.747 | 1 | 1 | |
2020 | 6.000.000 | 0 | 1.008.650 | 1 | ||
2019 | 15.000.000 | 0 | 2.273.400 | 1 |
Total number of partners: 74
Partner loyalty:
Frequent Partner: (> 2 projects): 12
Rare Partner: 62
Frequent / Rare Partner Ratio: 0.19
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-05-01 | International Human Microbiome Coordination and Support Action | IHMCSA | participant | 1.999.370 | 17 |
2021-03-01 | NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242 | A-TANGO | coordinator | 5.999.999 | 14 |
2020-04-01 | DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES | DECISION | coordinator | 6.000.000 | 25 |
2019-01-01 | MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response | MICROB-PREDICT | coordinator | 15.000.000 | 22 |